Global Orthobiologics Market Set to Grow Reaching US$ 8.1 Billion by 2033 at a CAGR of 3.0%

Orthobiologics Market
Orthobiologics Market

The global orthobiologics market is on a trajectory of substantial growth, poised to expand at a compound annual growth rate (CAGR) of 3.0% during the forecast period, according to recent market analysis. In 2023, the market boasted a share of US$ 6.0 billion, with projections indicating a significant rise to surpass US$ 8.1 billion by 2033.

The robust growth of the orthobiologics market is attributed to several key factors outlined in the market outlook. Increased healthcare budgets worldwide are driving the adoption of advanced medical equipment, particularly those leveraging cutting-edge technology. Moreover, the prevalence of bone-related disorders and injuries is fueling demand for orthobiologics, which offer innovative solutions for musculoskeletal health.

Get Access to Sample Now:

One of the notable trends contributing to market expansion is the rising adoption of viscosupplements to delay knee replacement surgeries, thereby enhancing patient outcomes and reducing healthcare costs. Additionally, the prospect of alleviating long-standing physical pain through non-invasive orthobiologics treatments is compelling end-users to embrace these advanced technologies.

Furthermore, the surge in product introductions is reshaping the landscape of orthobiologics, providing healthcare facilities with a diverse array of solutions to address musculoskeletal issues effectively. Urbanization and the consequent increase in accidents are further driving the demand for orthobiologics, as they offer efficient remedies for bone disorders and fractures.

The future of the orthobiologics market looks promising, with advanced integration systems and research and development initiatives paving the way for innovative biological substances that expedite the healing process for musculoskeletal injuries. Key products such as bone allografts, soft tissue allografts, and cartilage allografts are anticipated to witness substantial growth, offering optimal treatment solutions for knee and shoulder injuries.

As the orthobiologics market continues to evolve, stakeholders across the healthcare sector are poised to capitalize on emerging opportunities and advancements in orthopedic biologics. With a steadfast commitment to innovation and patient-centric care, the industry is set to redefine standards for musculoskeletal health and enhance the quality of life for millions worldwide.

Orthobiologics Market: Country-wise Breakdown

This summary highlights the growth potential of the orthobiologics market in three key regions:

  • United States: The leader in market share, with an expected value of US$ 2.8 billion by 2033. Factors driving this growth include:
    • Increased healthcare budget
    • Rising per capita income
    • Advancements in orthopedics
    • Preference for minimally invasive treatments
  • United Kingdom: This market is projected to reach US$ 339.9 million by 2033, fueled by:
    • Increased healthcare audits
    • Rising geriatric population and accident rates
    • Adoption of advanced diagnosis and treatment procedures
    • Growing awareness of alternative orthopedic treatments
  • India: Emerging as a leader in growth rate (CAGR) with a projected CAGR of 6.6% between 2023 and 2033. Key drivers include:
    • Rapid development of the healthcare sector
    • Adoption of advanced orthobiologic products
    • Integration of regenerative medicine with orthobiologics
    • Patient preference for alternative and regenerative treatments

Overall, the orthobiologics market shows promise for global growth, with the US holding the top spot and regions like India exhibiting significant growth potential.

Request Report Methodology:

The information you provided suggests that the market for orthobiologics is growing due to two main factors:

  • Higher Number of Accidents: This could be due to an increase in traffic accidents, sports injuries, or other types of injuries that damage bones, joints, or other tissues of the musculoskeletal system.
  • Advanced Orthopedic Procedures: The development of new and more sophisticated orthopedic procedures may be creating a demand for orthobiologics, which can be used to promote healing and repair damaged tissues.

Orthobiologics are a type of medical product that uses natural substances to help heal bones, joints, and other tissues. They can include things like bone grafts, cartilage grafts, and growth factors.

Here are some additional details you might find interesting:

  • Types of orthobiologics: There are many different types of orthobiologics, each with its own specific uses. Some common types include bone morphogenetic proteins (BMPs), platelet-rich plasma (PRP), and stem cells.
  • Applications of orthobiologics: Orthobiologics can be used to treat a variety of conditions, including fractures, arthritis, and sports injuries.
  • Benefits of orthobiologics: Orthobiologics offer a number of potential benefits over traditional treatments, such as promoting faster healing, reducing pain, and improving long-term outcomes.

Key Contributors of the Orthobiologics Market are:

  • Medtronic (Ireland)
  • Zimmer Biomet
  • DePuy Synthes (Johnson & Johnson Services, Inc.)
  • Stryker
  • Anika Therapeutics, Inc.
  • SeaSpine
  • Bioventus
  • RTI Surgical
  • MTF Biologics
  • Arthrex, Inc.
  • Smith & Nephew

Request Purchase Now:

Key Segments:

By Product Type:

  • Bone Growth Stimulators (BGS)
    • Non-invasive Electrical BGS
    • Invasive Electrical BGS
    • Ultrasound BGS
  • Viscosupplements
    • Single Injection Viscosupplements
    • Three Injection Viscosupplements
    • Five Injection Viscosupplements
  • Bone Graft Substitute
    • Allografts
    • Synthetics
    • Xenografts
    • Bone Morphogenetic Protein

By End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedics Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

About the Author

Ronak Shah

Associate Vice President at Future Market Insights is deeply committed to uncovering actionable insights for consumer and food and beverage players. She brings a unique blend of analysis, industry trends, and consumer behavior to put data into perspective.

What she makes out of data becomes a delight to read. She has authored many opinions, including for publications like Process Industry Informer and Spinal Surgery News, as she understands the market pulse and consumers' shifting preferences.

She likes to bring experts to a roundtable to weigh the impact of a trend on an industry. Catch up with her discussion on the impact of AI in packaging.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these